Literature DB >> 15542823

Ski negatively regulates erythroid differentiation through its interaction with GATA1.

Nobuhide Ueki1, Leiqing Zhang, Michael J Hayman.   

Abstract

The Ski oncoprotein dramatically affects cell growth, differentiation, and/or survival. Recently, Ski was shown to act in distinct signaling pathways including those involving nuclear receptors, transforming growth factor beta, and tumor suppressors. These divergent roles of Ski are probably dependent on Ski's capacity to bind multiple partners with disparate functions. In particular, Ski alters the growth and differentiation program of erythroid progenitor cells, leading to malignant leukemia. However, the mechanism underlying this important effect has remained elusive. Here we show that Ski interacts with GATA1, a transcription factor essential in erythropoiesis. Using a Ski mutant deficient in GATA1 binding, we show that this Ski-GATA1 interaction is critical for Ski's ability to repress GATA1-mediated transcription and block erythroid differentiation. Furthermore, the repression of GATA1-mediated transcription involves Ski's ability to block DNA binding of GATA1. This finding is in marked contrast to those in previous reports on the mechanism of repression by Ski, which have described a model involving the recruitment of corepressors into DNA-bound transcription complexes. We propose that Ski cooperates in the process of transformation in erythroid cells by interfering with GATA1 function, thereby contributing to erythroleukemia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15542823      PMCID: PMC529047          DOI: 10.1128/MCB.24.23.10118-10125.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  57 in total

1.  PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding.

Authors:  P Zhang; X Zhang; A Iwama; C Yu; K A Smith; B U Mueller; S Narravula; B E Torbett; S H Orkin; D G Tenen
Journal:  Blood       Date:  2000-10-15       Impact factor: 22.113

2.  Role of PML and PML-RARalpha in Mad-mediated transcriptional repression.

Authors:  M M Khan; T Nomura; H Kim; S C Kaul; R Wadhwa; T Shinagawa; E Ichikawa-Iwata; S Zhong; P P Pandolfi; S Ishii
Journal:  Mol Cell       Date:  2001-06       Impact factor: 17.970

3.  Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor beta signaling.

Authors:  J A Reed; E Bales; W Xu; N A Okan; D Bandyopadhyay; E E Medrano
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

4.  Interaction of the Ski oncoprotein with Smad3 regulates TGF-beta signaling.

Authors:  Y Sun; X Liu; E N Eaton; W S Lane; H F Lodish; R A Weinberg
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

5.  In vivo requirements for GATA-1 functional domains during primitive and definitive erythropoiesis.

Authors:  R Shimizu; S Takahashi; K Ohneda; J D Engel; M Yamamoto
Journal:  EMBO J       Date:  2001-09-17       Impact factor: 11.598

6.  Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor.

Authors:  W Xu; K Angelis; D Danielpour; M M Haddad; O Bischof; J Campisi; E Stavnezer; E E Medrano
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

7.  Signal-dependent N-CoR requirement for repression by the Ski oncoprotein.

Authors:  Nobuhide Ueki; Michael J Hayman
Journal:  J Biol Chem       Date:  2003-04-25       Impact factor: 5.157

Review 8.  Transcriptional regulation in acute promyelocytic leukemia.

Authors:  R J Lin; T Sternsdorf; M Tini; R M Evans
Journal:  Oncogene       Date:  2001-10-29       Impact factor: 9.867

Review 9.  Disruption of differentiation in human cancer: AML shows the way.

Authors:  Daniel G Tenen
Journal:  Nat Rev Cancer       Date:  2003-02       Impact factor: 60.716

Review 10.  Biological roles and mechanistic actions of co-repressor complexes.

Authors:  Kristen Jepsen; Michael G Rosenfeld
Journal:  J Cell Sci       Date:  2002-02-15       Impact factor: 5.285

View more
  13 in total

1.  Ski can negatively regulates macrophage differentiation through its interaction with PU.1.

Authors:  N Ueki; L Zhang; M J Hayman; M J Haymann
Journal:  Oncogene       Date:  2007-07-09       Impact factor: 9.867

2.  Dynamic transcription factor activity profiles reveal key regulatory interactions during megakaryocytic and erythroid differentiation.

Authors:  Mark T Duncan; Seungjin Shin; Jia J Wu; Zachary Mays; Stanley Weng; Neda Bagheri; William M Miller; Lonnie D Shea
Journal:  Biotechnol Bioeng       Date:  2014-07-14       Impact factor: 4.530

3.  Effects of hemin and thermal stress exposure on JWA expression.

Authors:  Ming Zhao; Rui Chen; Aiping Li; Jianwei Zhou
Journal:  Front Med China       Date:  2007-02

4.  The SKI proto-oncogene enhances the in vivo repopulation of hematopoietic stem cells and causes myeloproliferative disease.

Authors:  Sofie Singbrant; Meaghan Wall; Jennifer Moody; Göran Karlsson; Alistair M Chalk; Brian Liddicoat; Megan R Russell; Carl R Walkley; Stefan Karlsson
Journal:  Haematologica       Date:  2014-01-10       Impact factor: 9.941

5.  Peroxisome proliferator-activated receptor γ (PPARγ) mediates a Ski oncogene-induced shift from glycolysis to oxidative energy metabolism.

Authors:  Fang Ye; Hélène Lemieux; Charles L Hoppel; Richard W Hanson; Parvin Hakimi; Colleen M Croniger; Michelle Puchowicz; Vernon E Anderson; Hisashi Fujioka; Ed Stavnezer
Journal:  J Biol Chem       Date:  2011-09-14       Impact factor: 5.157

Review 6.  Ski and SnoN, potent negative regulators of TGF-beta signaling.

Authors:  Julien Deheuninck; Kunxin Luo
Journal:  Cell Res       Date:  2009-01       Impact factor: 25.617

7.  GATA-1 mediates auto-regulation of Gfi-1B transcription in K562 cells.

Authors:  Duen-Yi Huang; Yuan-Yeh Kuo; Zee-Fen Chang
Journal:  Nucleic Acids Res       Date:  2005-09-21       Impact factor: 16.971

8.  Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers.

Authors:  Alexandre Fagnan; Frederik Otzen Bagger; Maria-Riera Piqué-Borràs; Cathy Ignacimouttou; Alexis Caulier; Cécile K Lopez; Elie Robert; Benjamin Uzan; Véronique Gelsi-Boyer; Zakia Aid; Cécile Thirant; Ute Moll; Samantha Tauchmann; Amina Kurtovic-Kozaric; Jaroslaw Maciejewski; Christine Dierks; Orietta Spinelli; Silvia Salmoiraghi; Thomas Pabst; Kazuya Shimoda; Virginie Deleuze; Hélène Lapillonne; Connor Sweeney; Véronique De Mas; Betty Leite; Zahra Kadri; Sébastien Malinge; Stéphane de Botton; Jean-Baptiste Micol; Benjamin Kile; Catherine L Carmichael; Ilaria Iacobucci; Charles G Mullighan; Martin Carroll; Peter Valent; Olivier A Bernard; Eric Delabesse; Paresh Vyas; Daniel Birnbaum; Eduardo Anguita; Loïc Garçon; Eric Soler; Juerg Schwaller; Thomas Mercher
Journal:  Blood       Date:  2020-08-06       Impact factor: 25.476

9.  Proerythroblast Cells of Diamond-Blackfan Anemia Patients With RPS19 and CECR1 Mutations Have Similar Transcriptomic Signature.

Authors:  Beren Karaosmanoglu; M Alper Kursunel; Duygu Uckan Cetinkaya; Fatma Gumruk; Gunes Esendagli; Sule Unal; Ekim Z Taskiran
Journal:  Front Physiol       Date:  2021-06-11       Impact factor: 4.566

10.  The GATA1s isoform is normally down-regulated during terminal haematopoietic differentiation and over-expression leads to failure to repress MYB, CCND2 and SKI during erythroid differentiation of K562 cells.

Authors:  Christina Halsey; Marie Docherty; Mhairi McNeill; Derek Gilchrist; Michelle Le Brocq; Brenda Gibson; Gerard Graham
Journal:  J Hematol Oncol       Date:  2012-08-01       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.